Slideshow
Author(s):
These medical apps provided technology for caregivers to track symptoms, make appointments with doctors, monitor medications, and more.
Eplontersen Gains Positive CHMP Approval Recommendation for ATTR Polyneuropathy
Episode 122: RNA Therapeutics, Mivelsiran, and Treating Alzheimer Disease
NeurologyLive® Friday 5 — October 18, 2024
Special Episode: FDA Approves Donanemab for Early Symptomatic Alzheimer Disease
FDA Action Update, September 2024: Approvals, Designations, and Clearances
Exploring the Impact of Circadian Rhythms on Glial Function and Alzheimer Disease